Aug 08, 2026 — Digital Edition
Gerald Ideas
Independent Journalism & Insight
Feature

Cross talk between genetic and epigenetic mechanisms driving prostate · a modern approach

Cross talk between genetic and epigenetic mechanisms driving prostate ...

Cross talk between genetic and epigenetic mechanisms driving prostate
Cross talk between genetic and epigenetic mechanisms driving prostate

Cross talk between genetic and epigenetic mechanisms driving prostate cancer progression from a castration-sensitive prostate cancer (CSPC) to lineage plastic prostate cancer (LP-PCa), which ...

Frontiers
Frontiers

Our increasing understanding of the epigenetic mechanisms driving prostate cancer initiation and progression is fueling development of novel therapeutic strategies that can target these epi-genetic processes.

Prostate Cancer Epigenetics

Downregulation of BKCa inhibits prostate cancer cell proliferation
Downregulation of BKCa inhibits prostate cancer cell proliferation

Alterations in the epigenetic cityscape of prostate cancer cells compared with normal prostate tissues have a complex interplay with genetic alterations to drive prostate cancer initiation and progression. Indeed, mutations in genes encoding epigenetic enzymes are often observed in human cancers including prostate cancer.

Substantial advances in the understanding of epigenetic mechanisms in the pathophysiology of prostate cancer have been carried out, but translating preclinical achievements into clinical practice ...

Prostate cancer immunotherapy Improving clinical outcomes with a multi
Prostate cancer immunotherapy Improving clinical outcomes with a multi

Prostate Cancer Epigenome

Prostate cancer is a major health burden within the ever-increasingly aging US population. The molecular mechanisms involved in prostate cancer are diverse and heterogeneous. In this context, epigenetic changes, both global and gene specific, are ...

The underlying molecular basis of this resistance mechanism remains incompletely understood, but a suite of epigenetic mechanisms appear to play a central role in establishing, maintaining, and adapting cell-lineage transcriptional programs [6, 10-13].

Prostate Cancer Signaling Pathway
Prostate Cancer Signaling Pathway

Epigenetics regulation of prostate cancer

The epigenetic modifications change gene expression levels without altering the nucleotide sequence of the genome and play a vital role in cancer initiation, progression, and decreased sensitivity to treatment. Epigenetics includes 4 important mechanisms (Fig. 2).

Abstract Acquired or inherited genetic alterations either alone or in combination with epigenetic alterations are associated with prostate carcinogenesis and its progression toward advance metastatic or castration-resistant disease.

Downregulation of SEPTIN5 inhibits prostate cancer progression
Downregulation of SEPTIN5 inhibits prostate cancer progression

Deciphering the genetic and epigenetic architecture of prostate cancer

Further, in this chapter we delve into the underlying signaling mechanism , the advancements in targeting genetic and epigenetic alterations in prostate cancer. These findings have revealed promising targets for therapeutic advancements, aiming to understand and identify promising avenues for future therapies.

Pentamidine causes mtDNA reduction in prostate cancer cells A GSEA
Pentamidine causes mtDNA reduction in prostate cancer cells A GSEA
PDF Downregulation of SEPTIN5 inhibits prostate cancer progression
PDF Downregulation of SEPTIN5 inhibits prostate cancer progression
Oncology Letters
Oncology Letters
Downregulation of mTOR by lentivirus inhibits prostate cancer cell
Downregulation of mTOR by lentivirus inhibits prostate cancer cell
Brucine Suppresses Malignant Progression of Prostate Cancer
Brucine Suppresses Malignant Progression of Prostate Cancer
RNA m6a Methylation Regulator Expression in Castration Resistant
RNA m6a Methylation Regulator Expression in Castration Resistant
Model of prostate cancer progression Morphologic features of different
Model of prostate cancer progression Morphologic features of different

Prostate cancer is driven by interrelated genetic 1,2 and epigenetic 3 alterations. Known genetic contributors to sporadic prostate cancer are the presence of germline genetic variants that ...